GlassScriptPhysician profile
Vijay Agusala
NPI 1326675117
$3,445.97
in general payments reported to CMS, 2019-2025
12 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $696 · 2024: $1,480 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,445.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $996.18 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $531.96 | 2023-2024 | Acticor 7 Vr-T Dx, Amvia Edge, Edora 8 Dr-T |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $463.71 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $433.07 | 2023-2025 | Comet, Watchman Flx, Avvigo Guidance System |
| Abiomed | $359.62 | 2024-2025 | Impella |
| Abbott Laboratories | $196.77 | 2023-2025 | Aveir, Xience Skypoint, Navitor |
| W. L. Gore & Associates, INC. | $162.96 | 2025 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $123.15 | 2023 | |
| Novartis Pharmaceuticals Corporation | $57.32 | 2024 | |
| Biosense Webster, INC. | $53.93 | 2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $48.62 | 2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $18.68 | 2025 | Evoque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Agusala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.